As mentioned above, CENP-A acts as a transcriptional regulator and promotes DNMT1 (DNA Methyltransferase 1)-mediated PLA2R1 (Phospholipase A2 Receptor) promoter methylation, thereby reducing the expression level of PLA2R1 and augmenting breast cancer progression [182]. Here, PLA2R1 is linked to breast carcinoma.